Of 235 shares from an Ashland (ASH) stock award conversion, 69 were withheld for taxes.
Samuel Richardson, VP, Controller, and PAO of Ashland Inc., converted 235 restricted stock units into common shares on November 16, 2026. Out of these, 69 shares were withheld to cover tax liabilities related to the vesting. After the transaction, Richardson's direct holdings included 235 restricted stock units and 1,345 common shares.
109 shares were withheld for taxes as Ashland (ASH) CFO William Whitaker converted 367 stock units.
Ashland Inc.'s CFO, William Whitaker, converted 367 restricted stock units into common shares on November 16, 2026, at an acquisition price of $75.57 per share. During this transaction, 109 shares were withheld to cover tax liabilities associated with the vesting. After the conversion, Whitaker's reported post-transaction balance included 367 RSUs and 2,473 common shares, with the RSUs vesting in three equal installments.
70 shares withheld for taxes as Ashland (ASH) CFO William Whitaker converts stock units.
Ashland Inc.'s CFO, William Whitaker, converted 236 restricted stock units into common shares on November 13, 2026, at a price of $76.47 per share. In connection with this vesting, 70 shares were withheld to cover tax liabilities. Whitaker's post-transaction balance includes 474 restricted stock units, and the original RSU grant vests in three equal installments, contingent on his continuous employment.
Ashland Inc. Stock 12‑Month Price Target Raised to $82.9, Implies 8% Upside
Ashland Inc.'s average 12-month price target has been increased to $82.9 from $82.45 by 10 analysts, implying an 8% potential upside from its Nov. 13 closing price. The consensus rating for ASH remains "Buy" among 12 analysts, with 10 recommending "Buy" and 2 recommending "Hold."
Ashland Inc. remains a Buy with strong Q4FY26 results and potential takeover interest.
Ashland Inc. has maintained its "Buy" rating due to a positive financial outlook and interest from potential acquirers. The company met its Q4FY26 revenue and EBITDA expectations and anticipates a turnaround in FY2027 through pricing improvements and cost restructuring. These factors underscore confidence in Ashland's future growth and investor value.
Ashland Projects Earnings Recovery After Fiscal 2026 Decline
Ashland Inc. (NYSE: ASH) anticipates an earnings recovery in fiscal 2027 following a decline in 2026, driven by improved manufacturing productivity and strong demand for pharmaceutical and personal care ingredients. The company forecasts fiscal 2027 sales between $1.905 billion and $1.975 billion, with adjusted EBITDA ranging from $405 million to $435 million. This outlook comes after fiscal 2026 revenue increased 2% to $1.863 billion, but adjusted EBITDA fell 4% to $385 million.
Evonik interest in Ashland potential bid cooling - Bloomberg
Evonik's interest in acquiring chemicals maker Ashland has reportedly cooled, causing Ashland shares to fluctuate. Previously, other firms like Clayton, Dubilier & Rice, Clariant, Apollo Management, Carlyle Group, and CVC Capital had also shown interest in Ashland. Separately, Evonik executives are scheduled to meet with BASF SE executives after rejecting BASF's improved acquisition offer.
Ashland Inc stock hits 52-week high at 78.26 USD
Ashland Inc. (ASH) stock reached a 52-week high of $78.26, reflecting a 56% increase over the past year and 42% in the last six months. Despite trading at a P/E ratio of 140 and appearing overvalued by InvestingPro data, the company has maintained dividend payments for 56 consecutive years. Ashland also reported mixed fiscal fourth-quarter results, missing earnings expectations but showing strong cash generation and an optimistic outlook for fiscal 2027.
Ashland Sets Fiscal 2027 Sales and Adjusted EBITDA Outlook
Ashland Inc. has set its fiscal 2027 outlook, projecting sales between $1.905 billion and $1.975 billion and adjusted EBITDA from $405 million to $435 million. The company also expects capital expenditures of up to approximately $140 million and anticipates a stronger U.S. dollar to negatively impact sales and adjusted EBITDA. Key process improvements at its Hopewell facility are expected to increase output by about 25%.
What Ashland (ASH) Said on Its Q4 Earnings Call
Ashland (ASH) reported higher Q4 sales and adjusted earnings, driven by growth in pharmaceutical and personal care products, despite weaker manufacturing productivity in Specialty Additives. The company provided fiscal 2027 guidance expecting sales of $1.905 billion to $1.975 billion and adjusted EBITDA of $405 million to $435 million, with a focus on improving profitability and execution, particularly at its Hopewell facility. Growth was led by increased volume and favorable pricing, while the company plans for higher capital spending and continued commercial momentum.
Ashland reports fourth quarter and full-year fiscal 2026 results and issues outlook for fiscal 2027
Ashland (ASH) reported its fourth-quarter fiscal 2026 results, with sales up four percent to $498 million and an adjusted EPS of $1.12, despite a GAAP loss. The company also provided a fiscal 2027 outlook, projecting sales between $1,905 million and $1,975 million and Adjusted EBITDA of $405 million to $435 million. Growth was primarily driven by the Life Sciences and Personal Care segments, although Specialty Additives experienced lower demand.
Ashland Q4 2026 Earnings Call Transcript
Ashland Inc. reported strong fiscal 2026 with a 4% sales increase and a 2% rise in adjusted EBITDA, driven by growth in Life Sciences, Personal Care, and Specialty Additives. The company's strategic focus on "Globalize and Innovate" strategies led to significant sales growth and margin expansion in high-margin segments, despite raw material volatility and operational challenges at their Hopewell site. For fiscal 2027, Ashland projects sales between $1.905 billion and $1.975 billion and adjusted EBITDA from $405 million to $435 million, emphasizing sustained growth, improved manufacturing performance, and innovation as a long-term driver.
Form 8K Ashland Inc For: 3 November By Investing.com
This article from Investing.com announces that Ashland Inc. has filed a Form 8K for November 3rd. The brief piece indicates that the filing is available for review, with the company's stock symbol ASH mentioned along with a positive price performance of +3.11%.
Ashland earnings up next as bidders eye specialty chemicals maker
Ashland Inc. (ASH) is set to report its fourth-quarter fiscal 2026 results, with analysts anticipating a 25% sequential jump in profit. The announcement comes as several private equity firms, including Clayton, Dubilier & Rice, Apollo Management, and Carlyle Group, reportedly eye the specialty chemicals maker for a potential sale, following pressure from activist investor Ancora. Investors will be scrutinizing earnings quality, margin performance, operational stability, and management's commentary on the strategic review process.
Ashland Sets November 3 Release for Fiscal 2026 Results
Ashland Inc. (NYSE: ASH) is scheduled to release its fourth-quarter and fiscal 2026 financial results on November 3, 2026, at approximately 5 p.m. Eastern Time. This will be followed by a presentation to securities analysts on November 4 at 9 a.m., featuring key executives including Chairman and CEO Guillermo Novo and CFO William Whitaker. The company will provide detailed management remarks and supporting materials on its investor relations website.
Franklin Templeton reports a client-held stake above 5% in Ashland (ASH).
Franklin Templeton, Inc. has reported a beneficial ownership of 2,547,046 shares, representing a 5.6% stake in Ashland Inc. (ASH), through its investment management clients. These clients retain the rights to receive dividends and sale proceeds from these shares. The filing, an amended Schedule 13G, details the sole voting and dispositive powers held by Franklin Mutual Advisers, LLC over a significant portion of these shares.
Press Release: Ashland Sets Date for Fourth-quarter Fiscal 2026 Earnings Release and Conference Call Webcast
Ashland Inc. has announced it will release its fourth-quarter fiscal 2026 earnings results after the market closes on Tuesday, November 17, 2026. The company will also host a live webcast of its earnings conference call on Wednesday, November 18, 2026, at 9:00 a.m. ET, during which management will discuss the results.
Ashland sets date for fourth-quarter fiscal 2026 earnings release and conference call webcast
Ashland Inc. (NYSE: ASH) announced its plan to release fourth-quarter fiscal 2026 earnings on Tuesday, November 3, 2026, at approximately 5 p.m. ET. A live webcast with securities analysts, including an executive summary and detailed remarks, will follow on Wednesday, November 4, at 9 a.m. ET. Key company executives, including CEO Guillermo Novo and CFO William Whitaker, will participate in the webcast.
Ashland Inc. Estimates – NYSE:ASH
This article provides an overview of Ashland Inc. (NYSE: ASH) financials and analyst estimates on TradingView. It allows users to explore reported financial data, compare actual results with average, high, and low estimates, and visualize trends over time across income statements, balance sheets, and cash flow statements. The platform emphasizes that this information is not investment advice and encourages users to conduct their own research.
Ashland Inc in Delaware U.S. Congress
This article from OpenSecrets.org details Ashland Inc.'s campaign contributions in Delaware's U.S. Congress races during the 2012 cycle. Ashland Inc., categorized under Chemicals, contributed $33,150, primarily to Democratic candidates like Tom Carper, Chris Coons, and John Carney Jr. The data highlights the company's financial influence in Delaware politics.
Ashland schedules November 4 results: Ashland stock gains 2.40 percent
Ashland (ASH) has scheduled its next earnings report for November 4, 2026. The company's fiscal third-quarter sales rose 7.00 percent to USD 497.00 million, while its stock gained 2.40 percent in European trading. Despite sales growth, the company faced uneven operating performance, with overall adjusted EBITDA falling year over year.
ConnectM Forms Strategic Advisory Board to Drive AI Energy Infrastructure Growth; Appoints Ashland Director Ashish Kulkarni, Former Fortress and Shumway Capital Executive Neil Bhatia, and Las Olas Capital CEO Jim McCabe
ConnectM Technology Solutions, a U.S.-based company focused on AI energy infrastructure, announced the formation of a Strategic Advisory Board. This board includes Ashish Kulkarni (Ashland Inc. director), Neil Bhatia (former Fortress and Shumway Capital executive), and Jim McCabe (Las Olas Capital CEO). The board's primary goal is to accelerate ConnectM's AI energy infrastructure business, which provides power, cooling, storage, and intelligent energy management for data centers, and to enhance profitability and attract long-term institutional shareholders.
UBS cuts Ashland target to USD 80.00 while Ashland stock sits 12.19 percent below target
UBS has lowered its price target for Ashland (ASH) from USD 83.00 to USD 80.00, placing the stock 12.19 percent below this new target. Despite the reduction, the target remains above the stock's current NYSE price of USD 71.31. Ashland currently offers a 2.00 percent dividend yield, with its stock trading at EUR 63.50.
Ashland Inc (AHT.MU) Analyst insights, Price targets and Recommendations
This article provides analyst insights, price targets, and recommendations for Ashland Inc (AHT.MU). It details recent upgrades and downgrades from various financial institutions like UBS, Morgan Stanley, Wells Fargo, Evercore ISI Group, and Mizuho, alongside the company's current stock price.
Ashland gains on report bids made last week - Dealreporter
Ashland's stock rose 3% following a report that the company received initial bids last Friday for a potential sale. Private equity firm Clayton, Dubilier & Rice is reportedly partnering with Clariant for a bid, while Apollo Management and Carlyle Group are also interested. This development comes after months of activist investor pressure for Ashland to explore a sale.
Ashland (ASH) Earnings Date and Reports 2026 $ASH
Ashland (ASH) reported Q2 2026 earnings on April 28, 2026, with an EPS of $0.91, missing analyst estimates of $0.97, and revenue of $482 million, below the $485.61 million consensus. The company's upcoming Q4 2026 earnings are estimated for Tuesday, November 3, 2026. Ashland anticipates its earnings to grow by 18.16% next year, from $3.58 to $4.23 per share.
A director acquires 212 stock units in Ashland (ASH), bringing his balance to 2,407.
Ashland Inc. (ASH) director Sanat Chattopadhyay acquired 212 Common Stock Units on September 30, 2026, under the company's Deferred Compensation Plan for Non-Employee Directors. This transaction brings his total post-transaction balance to 2,407 units, including those acquired through cash dividends. The units, valued at $67.92 each, are payable in common stock upon his separation from service as a director.
Ashland (ASH) director Steven D. Bishop acquires 368 stock units at $67.92 each under a compensation plan.
Ashland director Steven D. Bishop acquired 368 Common Stock Units on September 30, 2026, as part of Ashland’s Deferred Compensation Plan for Non-Employee Directors. Each unit, valued at $67.92, is equivalent to one share of Ashland common stock. These units will be paid out in common stock upon his separation from service as a director, subject to any deferral election, bringing his total holdings to 6,123 units.
ASH4041064 Bond Profile: Coupon and Redemption
This article provides a detailed profile of the Ashland Inc. 6.875% 15-MAY-2043 bond (FINRA ASH4041064). It covers key facts about the issuer, Ashland Inc., including its business segments, and outlines essential bond details such as issue and maturity dates, face value, coupon rate, and semi-annual payment schedule. The profile also touches upon credit risk assessment and bond redemption information.
ASH's Shares Rally 30% in 6 Months: What's Driving the Upside?
Ashland Inc.'s shares have rallied 30.2% over the past six months, outperforming its industry, driven by improved margin resilience from cost reductions, portfolio optimization, and a stronger business mix. The company's strategic shift to a business-unit-focused operating model, alongside strong free cash flow generation and a new $1-billion share repurchase authorization, are key factors supporting this growth and investor confidence. Ashland is also prioritizing higher-value, consumer-oriented specialty ingredients and innovation to further strengthen its margin profile.
Ashland Expands Crop Protection Portfolio With TVO Dispersant
Ashland Inc. has launched agrimer eco-disperse OD TVO, a new crop-protection dispersant globally. This product, derived from transformed vegetable oil, expands Ashland's Transformed Vegetable Oils technology platform and is designed for non-aqueous crop-protection formulations, offering both performance and sustainable benefits. The company aims to meet demand for biodegradable, microplastic-free materials while stabilizing active ingredients and improving leaf adhesion and rain fastness.
Ashland Inc. Extends European Receivables Securitization Facility Through 2029
Ashland Inc. has extended its European accounts receivable securitization program until September 21, 2029, as revealed in an 8-K filing. The facility maintains an aggregate revolving limit of €125 million, with Bank of America Europe DAC taking over as the Committed Purchaser from Bank of America, N.A. The original Receivables Purchase Agreement and Master Framework Agreement from October 19, 2023, were amended and restated to reflect these changes.
Ashland showcases innovation platforms and growth opportunities at Innovation Day 2026
Ashland recently held its Innovation Day 2026 webcast, where company leaders presented their innovation strategy and expanding commercial opportunities to analysts, investors, and industry stakeholders. The event highlighted Ashland's technology platforms and showcased how science-driven innovation is leading to scalable solutions and sustainable growth in key markets. A replay of the webcast and supporting materials are available on Ashland's investor relations website for those who missed the live event.
Form 4 Ashland Global Holdings Inc For: 23 September By Investing.com
This article from Investing.com reports on a Form 4 filing for Ashland Global Holdings Inc. for September 23, 2026. Form 4s disclose changes in beneficial ownership of company stock by insiders. The article provides the title and date of the filing but no further details regarding the content of the Form 4.
Ashland (ASH) technology chief acquires shares through stock units; 3,647 shares are withheld for taxes.
Ashland's SVP and CTO, Musa Osama M, converted 10,418 restricted stock units into common shares on September 21, 2026, with a reported value of $69.06 per share. A total of 3,647 shares were withheld to cover tax liabilities associated with the vesting. The transaction increased his direct common stock holdings to 37,577 shares.
Ashland launches nature-based dispersant for crop protection
Ashland Inc. (NYSE:ASH) has globally launched agrimer eco-disperse OD TVO, a new nature-based polymeric dispersant for non-aqueous crop protection formulations. This product, derived from transformed vegetable oil, is designed to stabilize and disperse water-insoluble active ingredients, addressing challenges like settling and nozzle clogging. It is biodegradable and microplastic-free, aligning with Ashland's commitment to sustainable commercial solutions.
A new crop-protection ingredient comes from vegetable oil. It is inherently biodegradable and microplastic-free.
Ashland Inc. (NYSE: ASH) has globally launched agrimer™ eco-disperse OD, a patented, nature-based polymeric dispersant derived from Transformed Vegetable Oils (TVO™). This new ingredient is designed for non-aqueous crop protection formulations, offering inherent biodegradability and being microplastic-free. It aims to enhance formulation performance, stability, and application efficiency while meeting sustainability and regulatory requirements for the agrochemical industry.
Ashland scales Transformed Vegetable Oils technology
Ashland Inc. has launched agrimer™ eco-disperse OD, a new polymeric dispersant based on its Transformed Vegetable Oils (TVO™) technology platform. This nature-based, inherently biodegradable, and microplastic-free product is designed for non-aqueous crop protection formulations, helping formulators achieve both sustainability and performance objectives. The introduction reinforces Ashland's strategy to innovate and strengthen long-term value creation through sustainable solutions in the crop care market.
Ashland Innovation Day to be held September 17, 2026
Ashland Inc. (NYSE: ASH) will host an Innovation Day webcast on September 17, 2026, from 9:00 am to 11:00 am ET. The event will feature Ashland leadership providing updates on the company's innovative Technology Platforms, their commercial progress, and scalability. Attendees will also have the opportunity to engage in a moderated Q&A session with executives and senior technology leaders.
Ashland to host Innovation Day for analysts and investors
Ashland Inc. (NYSE: ASH) will host a virtual Innovation Day on September 17, 2026, for analysts and investors, providing an updated view of its technology platforms, commercial progress, and scalability. The event will feature presentations from Ashland executives and senior technology leaders, detailing innovations poised to impact key markets and drive organic growth. Participants will also have a moderated Q&A session.
Ashland to host Innovation Day for analysts and investors
Ashland Inc. (NYSE: ASH) will host a live Innovation Day webcast for analysts and investors on September 17, 2026, from Wilmington, Delaware. The event will provide updates on Ashland's Technology Platforms, commercial progress, and scalability, featuring presentations from key executives. Participants will have the opportunity for a Q&A session and can register online, with a webcast and replay available on Ashland's investor website.
Here's Why We're Wary Of Buying Ashland's (NYSE:ASH) For Its Upcoming Dividend
The article "Here's Why We're Wary Of Buying Ashland's (NYSE:ASH) For Its Upcoming Dividend" is provided without any substantive content. The page appears to be an error page or a minimalist template from Sahm Capital Financial Company, displaying only navigation links, legal information, and contact details, rather than the expected financial analysis.
Ashland launches intestinal permeation enhancer for oral drugs
Ashland Inc. (NYSE:ASH) has commercially launched permexa sodium caprate, an intestinal permeation enhancer designed for oral peptide, biologic, and low-permeability drug products. This new excipient targets pharmaceutical developers creating oral alternatives to injectable therapies, including treatments for diabetes, weight loss, and metabolic disorders. The product is designed to improve formulation consistency, process robustness, and scalability in drug manufacturing, using an IP-protected process to support tablet production.
Ashland advances high-growth oral biologics delivery applications with launch of permexa™ sodium caprate
Ashland Inc. has launched permexa™ sodium caprate, a high-performance intestinal permeation enhancer for oral peptide and biologic drug products, including GLP-1 agonists. This excipient aims to improve formulation consistency, process robustness, and scalability in drug manufacturing, addressing key challenges in the rapidly growing oral biologics market. The company has seen significant interest from pharmaceutical developers and plans further product expansions in this area.
A new Ashland ingredient is designed to help make peptide medicines by mouth
Ashland (NYSE: ASH) has launched permexa™ sodium caprate, an intestinal permeation enhancer designed to facilitate the oral delivery of peptides, biologics, and low-permeability drugs, including GLP-1 agonists. This new excipient addresses challenges in formulation consistency, process robustness, and scalability for oral drug products, combining established sodium caprate functionality with improved pharmaceutical processing performance. The launch follows significant interest and positive feedback from pharmaceutical, biotech, and CDMO organizations globally, as Ashland expands its portfolio for oral biologics delivery.
Ashland Inc. (NYSE:ASH) Receives Consensus Rating of "Moderate Buy" from Brokerages
Ashland Inc. (NYSE:ASH) has received a "Moderate Buy" consensus rating from twelve brokerages, with an average 12-month price target of $73.90. Institutional investors hold a significant 93.95% of Ashland's shares, and the company recently declared a quarterly dividend of $0.42 per share, yielding 2.3%. The stock opened at $73.33, trading above its 200-day moving average.
Massachusetts Financial Services (ASH) discloses 4.5% Ashland Inc. stake
Massachusetts Financial Services Company has filed an amended Schedule 13G, disclosing a beneficial ownership of 4.5% in Ashland Inc. common stock as of June 30, 2026. This translates to 2,037,663 shares, with MFS holding sole voting power over 2,032,989 shares and sole dispositive power over all reported shares, indicating a passive investment below the 5% threshold.
Ashland Inc. (ASH) SVP converts 1,806 RSUs; 526 shares withheld for taxes
Ashland Inc.'s SVP, GC & Secretary, Robin E. Lampkin, converted 1,806 Restricted Stock Units (RSUs) into common shares on August 11, 2026. A total of 526 shares were withheld at $74.58 each to cover tax liabilities. This transaction also corrected a previous report regarding the initial RSU grant.
Leon Cooperman Buys Ashland Inc (ASH) -- Shares Look 9% Overvalued on GF Value
Leon Cooperman's Omega Advisors significantly increased its stake in Ashland Inc (ASH) by adding 1,215,000 shares, bringing his total holdings to 2,915,000 shares, representing 6.77% of his portfolio and 6.40% of Ashland's outstanding shares. Despite this strong vote of confidence, GuruFocus's GF Value model suggests Ashland shares are currently about 9% overvalued at $74.58 compared to an intrinsic value of $68.64. The company, a specialty materials leader, shows strong financial health with a Piotroski F-Score of 8 but faces operational headwinds with negative revenue and earnings growth.
Ashland Inc. Updates Board Committee Roles for Newly Appointed Directors Spizzo and Thomas
Ashland Inc. has announced updates to its Board of Directors' committee assignments for new directors Allen A. Spizzo and Peter T. Thomas, effective August 7, 2026. This information was disclosed in an amended current report filed on August 10, 2026. The article indicates that further details are available upon logging in or creating an account.